Krempa David Insider Trades & Stock Holdings

Chief Business Officer · Eton Pharmaceuticals, Inc. · Latest filing Oct 6, 2026

Krempa David, Chief Business Officer at Eton Pharmaceuticals, Inc. has 1 Form 4 trade on file since Oct 6, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($229.41K), net -$229.41K. Latest filing: disposed of 4.17K shares of $ETON on Oct 6, 2026 at $55.07.

Trades on file

1

Open-market bought

$0

Open-market sold

$229.41K

Net open-market

-$229.41K

Latest filing

Oct 6, 2026

All insider trades by Krempa David

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 6, 2026	$ETON	Sell (Open-market sale)	4.17K	$55.07	$229.41K			-2.6%			Chief Business Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Krempa David traded

• $ETON

Frequently asked questions

Has Krempa David been buying or selling stock?

Krempa David has 0 open-market purchases and 1 open-market sale on file, net -$229.41K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Krempa David's latest insider trade?

disposed of 4.17K shares of $ETON on Oct 6, 2026 at $55.07.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.